Category:

Prices for 50 hospital drugs have risen 10-fold over 8 years…Generic injection meds in short supply as producers drop out…With most products, you’d expect a flood of new supply to quickly drive back down a price spike caused by a temporary shortage. Not so in the topsy-turvy world of hospital pharmaceuticals…All sorts of medications, from treatments for irregular heartbeats to supplies as basic as saline solution, have shot up in price as common hospital drugs are increasingly, and sometimes critically, in short supply. The reasons for the shortages are varied: creaky old factories, an FDA crackdown on quality control, companies exiting the market for more lucrative opportunities and fewer producers in the wake of a wave of mergers and acquisitions…“It’s a broken market," said Stephen Schondelmeyer, a pharmacist and economist at the University of Minnesota who has studied drug prices. "Drug companies know there is going to be an end to this blank check era and they are pushing for whatever they can get."

Ohio Pharmacists Association, the state organization representing Ohio’s pharmacist practitioners, announced their opposition to the Ohio Marijuana Legalization Initiative, Issue 3, which if passed which would place legalized marijuana and a protected oligopoly of select commercial marijuana growers into the Ohio Constitution…OPA is unconvinced that marijuana is appropriate or beneficial as a form of treatment for illness or disease. Further, OPA rejects any medical marijuana proposal that removes the function, counsel, and expertise of the prescriber and pharmacist from the prescription process, as Issue 3 does…“If there is going to be a legitimate discussion about marijuana policy or the possible effectiveness of marijuana for medical purposes, then let’s have it. But ‘Responsible Ohio’ bypasses the discussion altogether in an effort to benefit to a few wealthy investors. Issue 3 is a slap in the face to Ohioans who genuinely care about sensible marijuana policy.”

Abstract

Objectives To improve understanding of the logistics of transitions of care (TOC) clinics and to provide guidance to pharmacists in developing and implementing a new TOC clinic or improving an existing one.

Setting Outpatient TOC clinic within an ambulatory care practice.

Practice description Two general internal medicine practices collaborated with a university health system to create an interdisciplinary TOC clinic to improve quality and continuity of patient care. The clinic accommodates any patients of the practice who are not able to get an appointment with their primary care physician within 1 to 2 weeks of discharge from any hospital. Physician residents, an attending physician, a clinical pharmacist, a nurse, medical assistants, and a social worker (if necessary) are involved in the patient's care during the transition process.

Practice innovation Pharmacists can play a vital role in developing and implementing a TOC clinic or enhancing a current one. There are many logistical components to consider in developing a clinic, and this article provides guidance in the various steps required in creating a clinic, including support and coordination, personnel, workflow, operations, reimbursement, marketing, metrics, and measures.

Conclusion This tool may help pharmacists implement or enhance an outpatient TOC clinic to improve patient care, quality, and continuity.

(full text req. subscrip.)

Hortense Jones of Durham...2015 Pharmacy Technician of the Year…Jones works at Durham’s Lincoln Community Health Center as the pharmacy technician supervisor, where she oversees a team of 11 pharmacy technicians…"I am truly humbled by this honor, but this is about our pharmacy team more than me," Jones said. "My leadership philosophy is to find the strengths of each employee and build an essential role for them on the team that matches their assets. As a result, they become fully engaged in advancing patient safety."

“Pharmacy is first and foremost a commercial enterprise and allowing pharmacists powers to prescribe and treat patients will lead to serious conflicts of interest.”…The President of the Irish Medical Organisation has issued a strong warning of the risks that will arise for patient health and safety if pharmacists are given permission to expand their role into areas which are more properly undertaken by doctors. Due to economic reasons pharmacists are seeking to expand their professional roles and move their scope of practice into the treatment and management of patients thus undermining the role of doctors and the patient/doctor relationship. Dr. Ray Walley said that the IMO (Irish Medical Organisation) will strongly oppose attempts to allow pharmacists increase their roles in respect of activities like managing repeat prescriptions, diagnosing minor ailments, Chronic Disease Management and any further expansion of vaccination programmes.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, discusses some of the ways in which e-prescribing trumps traditional prescriptions. (video)

As part of its advocacy and community outreach efforts during American Pharmacists Month, the American Pharmacists Association is partnering with the co-chairs of the House Community Pharmacy Caucus, the National Association of Chain Drug Stores, the National Community Pharmacists Association, the American Society of Health-System Pharmacists, and Walgreens to host the 3rd Annual Capitol Hill Health Fair on October 28. Flu shots and health screenings, including bone density, glucose, cholesterol, blood pressure, and body composition will be available to members of Congress, staff, and the general public in the Rayburn Foyer in the Rayburn House Office Building from 10:00 am to 2:00 pm.

Pharmacists from Walgreens and student pharmacists from:

• University of Maryland Eastern Shore School of Pharmacy
• University of Maryland School of Pharmacy
• Notre Dame of Maryland University School of Pharmacy
• Howard University College of Pharmacy
• Shenandoah University Bernard J. Dunn School of Pharmacy
• Virginia Commonwealth University School of Pharmacy

The IPU (Irish Pharmacy Union) has reacted angrily to claims made in a statement about Community Pharmacists issued by the IMO (Irish Medical Organisation) this afternoon, calling it an ‘unprecedented and unfounded attack on the pharmacy profession’…The IMO claim, ‘that there is a risk to patient’s health and safety if pharmacists are given permission to expand their role into areas which are more properly undertaken by doctors’ goes against international evidence that clearly shows the benefits of expanding the role of pharmacists in areas such as providing treatment for minor ailments and vaccination services…Various GP organisations have pointed out that general practice in Ireland currently faces a manpower crisis, which they claim will be worsened by the expansion of free GP care. In England, Scotland and Canada, where demand for GP services exceeds the available capacity, the unique skills and expertise of pharmacists have been used to enhance access to healthcare, generating considerable benefits to both patients and the State...

FDA has once again delayed its enforcement of product tracing requirements for pharmacies under the Drug Supply Chain Security Act...Although these track-and-trace requirements took effect on July 1, 2015, the FDA said it would not enforce the product tracing obligations for pharmacies until November 1, 2015, which it has now extended to March (March 1,2016)…FDA granted this latest extension because “some dispensers—primarily smaller, independent pharmacies and health systems—have expressed that they need additional time,” …In the meantime, pharmacies that do not capture and maintain product tracing information, or accept prescription drugs without product tracing information prior to or during a transaction, will not be penalized…this compliance policy does not extend to other requirements for dispensers under the DSCSA, which include verification related to suspect and illegitimate product (including quarantine, investigation, notification, and record keeping) and engaging in transactions only with authorized trading partners.

Health systems’ interest in gaining entry to the specialty-pharmacy market should not be a surprise, considering that specialty drug sales are growing at rates reported to be approximately 19% per year… the 340B pricing program could offer substantial incentives to certain qualifying health systems when they retain specialty-pharmacy prescriptions… Add in the trend of health systems’ entry into risk-sharing contracts, the formation of accountable care organizations, and the consolidation and merging of specialist physician practices… Health systems bring a number of advantages to the specialty marketplace… full integration and availability of clinical information to multidisciplinary health care providers allows for a level of care coordination that is unlikely to be matched by unaffiliated pharmacies.